Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy

Clinical Validation of the Perin Health Patch Electrocardiogram Monitoring Device: A Multi-Component Study Evaluating Signal Quality, Placement Tolerance, and Long-Term Performance

The goal of this clinical trial is to test how accurately and reliably a new chest-worn device called the Perin Health Patch measures heart rhythms (ECG) in adults aged 22 and older. The main questions it aims to answer are:

• How accurately does the Perin Health Patch measure heart rhythm compared to standard hospital ECG monitoring equipment?
• Does the patch still work properly if it's placed slightly off from the exact recommended position on the chest?
• Does the patch maintain good performance when worn continuously for 15 days?

The study has three parts that test different aspects of the device. Participants will:

• Wear the Perin Health Patch on their chest along with standard ECG monitoring equipment for comparison
• Have ECG recordings taken while sitting quietly for 15 minutes
• For the placement study: have the patch placed in several different positions to test if small placement errors affect performance
• For the long-term study: wear the patch continuously for 15 days at home with regular check-ups on days 1, 7, 10, and 15

The study will include both healthy adults and people with heart or lung conditions like heart failure, COPD, high blood pressure, or diabetes to test how well the device works for different types of patients. Researchers will compare the heart rhythm measurements from the chest patch to standard medical monitoring equipment to determine if the patch is accurate enough for medical use. Some participants will complete just one part of the study, while others may participate in multiple parts depending on which aspect of the device is being tested.

Study Overview

• Status: Completed
• Conditions: Electrocardiography; Monitoring, Physiologic; ECG
• Intervention / Treatment: Device: Chest-Worn ECG Monitoring Device

• Study Type: Observational
• Enrollment (Actual): 255

Contacts and Locations

Study Locations

• United States
  • California
    • Woodland Hills, California, United States, 91364
      • Perin Health Devices

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Participants will be recruited from multiple clinical sites including hospital settings, clinical research facilities, and home healthcare providers. The population includes both healthy adult volunteers and patients with chronic cardiovascular or pulmonary conditions such as COPD, congestive heart failure, hypertension, coronary artery disease, chronic kidney disease, and diabetes. Recruitment targets a demographically diverse sample representative of the intended use population for remote cardiac monitoring, with specific attention to age, sex, BMI, and racial/ethnic diversity to ensure robust validation across patient subgroups commonly encountered in clinical practice.

Description

Inclusion Criteria:

• Adults 22 to 90 years of age
• Healthy or chronic cardiopulmonary conditions or recent procedures
• Able to comply with study procedure

Exclusion Criteria:

• Pediatric or adolescent patients (age ≤21 years)
• Pacemaker
• A history of skin reactions to medical adhesives
• Any psychosocial condition or circumstance that, in the opinion of the investigator, would interfere with the conduct of the study or the patient's care and/or safety
• Pregnant
• Current participation in any other clinical study
• Refusal to participate

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
ECG Timing Interval Equivalence Between Perin Health Patch and Reference Holter Monitor	Equivalence of ECG measurements between the investigational chest patch and FDA-cleared Holter monitor using Two One-Sided Tests (TOST) statistical methodology. ECG recordings are taken simultaneously from both devices while participants sit quietly for comparison. Equivalence is demonstrated when confidence intervals for mean differences fall within pre-specified clinical margins for key ECG timing intervals including QT interval, QRS duration, and R-R interval. Signal morphology similarity is assessed using Pearson correlation coefficient (where 1.0 indicates perfect similarity) and normalized root mean square error (where 0% indicates identical signals).	During single 15-minute recording session and up to 15 days of continuous monitoring

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Heart Rate Measurement Accuracy	Accuracy of heart rate measurements from the investigational device compared to the reference Holter monitor. Heart rate is calculated from R-R intervals during simultaneous ECG recordings. Accuracy is assessed using mean absolute error between devices, where lower values indicate better agreement.	During single 15-minute recording session and up to 15 days of continuous monitoring
ECG Signal Quality Equivalence	Comparison of signal quality between the investigational device and reference monitor using signal-to-noise ratio analysis. Signal quality is measured in decibels (dB), where higher values indicate cleaner signals with less noise interference. Equivalence is assessed using statistical comparison methods to determine if signal quality differences fall within clinically acceptable ranges.	During single 15-minute recording session and up to 15 days of continuous monitoring
Device Adhesion Success Rate During Extended Wear	Percentage of participants who successfully complete the full monitoring period without device adhesion failure. Adhesion failure is defined as device detachment that prevents reliable ECG signal acquisition. Success is measured by the proportion of participants maintaining adequate device adherence throughout the intended wear duration.	Over 15-day continuous monitoring period

Collaborators and Investigators

• Sponsor: Perin Health Devices

Study record dates

Study Major Dates

• Study Start (Actual): May 21, 2025
• Primary Completion (Actual): July 15, 2025
• Study Completion (Actual): July 15, 2025

Study Registration Dates

• First Submitted: August 22, 2025
• First Submitted That Met QC Criteria: August 22, 2025
• First Posted (Estimated): August 29, 2025

Study Record Updates

• Last Update Posted (Estimated): August 29, 2025
• Last Update Submitted That Met QC Criteria: August 22, 2025
• Last Verified: August 1, 2025

More Information

Terms related to this study

• Keywords: ECG validation study; electrocardiogram accuracy
• Other Study ID Numbers: TP-25-001

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: No